Allied Market Research
Loading...
0
New
New
2022
Organ-on-chip Market

Organ-on-Chip Market by Type (Heart on chip, Human on chip, Intestine on chip, Kidney on chip, Liver on chip, Lung on chip): Global Opportunity Analysis and Industry Forecast, 2020-2030

A02223
Pages: 200
Mar 2022 | 22824 Views
   
Author(s) : Madhuvanti Balkrishna Divekar , Onkar Sumant
Tables: 88
Charts: 49
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Organ-on-chip Market

Request Now !

Organ-on-Chip Market Research, 2030

The global organ-on-chip market was valued at $103.44 million in 2020, and is projected to reach $1.6 billion by 2030, growing at a CAGR of 31.1% from 2021 to 2030.Organ-on-chip is a type of artificial organ that simulates human organs. It is a multichannel 3D micro-fluidic cell culture device, which stimulates activities, mechanisms, and physiological responses of organs. The combination of labs-on-chips (LOCs) and cell biology has allowed researchers to examine human physiology in an organ-specific environment, resulting in the development of a new model of in vitro multicellular human organisms. This chip develops a narrow channel for the blood and air flow in organs including, lung, gut, brain, liver, and heart. These devices are developed on a microchip that contains continuously perfused chambers colonized by living cells arranged to stimulate tissues and organ level physiology. Organ-on-chip is a device that is used to nurture internal organs with the help of silicone.

COVID-19 outbreak is anticipated to have a positive impact on the organ-on-chip market. A huge number of clinics and hospitals across the globe were restructured to increase the hospital capacity for patients diagnosed with COVID-19. Nonessential procedures took a potential backlog, owing to rapid rise in COVID-19 cases. The lockdown led to disruption of manufacturing and transportation of healthcare essentials. However, during the COVID-19 pandemic, organ-on-chip emerged as a promising technology for the development of drugs and vaccines, which were under research and clinical trials for the infection. Thus, it had a significantly positive impact during the pandemic.

Get more information on this report : Request Sample Pages

Organ-on-chip is a potentially game changing technology that combines tissue engineering and microfluidics. These technologies are predicted to provide effective answers to long standing issues in medication discovery and individualized disease treatment. It plays a major role in drug development studies, thus boosting the organ-on-chip industry.

The global organ-on-chip market is driven by increase in its applications in the healthcare sector, rise in demand for drug screening, and surge in demand for lung-based organ culture & kidney applications. Surge in alternative of animal testing by research activities on organ-on-chip devices for new drug development is expected to majorly boost the organ-on-chip market in upcoming years.

In addition, surge in demand for organ-on-chip devices in the healthcare industry is expected to boost the global organ-on-chip market. Real-time imaging, in vitro analysis of biochemical, and genetic & metabolic activities of living cells in a functional tissue are some of the applications of organ-on-chip devices in the healthcare industry. Advancements in cell biology, microfabrication, and microfluidics have led to increase in adoption of organ-on-chips, thereby fueling the organ-on-chip market growth.

Increase in demand for organ-on-chips in drug screening, rise in demand for lung- & kidney-based organ culture devices is expected to boost the organ-on-chip market size. Moreover, the shortage of donor organs and availability of laboratory-engineered functional organs are expected to be a major advantage to cater to the growing demands of organs transplantation. However, high cost of the organ chip device and the development of organ-on-chip (OOC) technology is still in its nascent stage, and is expected to restrain growth of the market. Conversely, considerable rise in healthcare expenditure across the globe has led to the increase of organ-on-chip market size. Emerging economies possess high potential for organ-on-chip market. Increase in number of chronic diseases, high requirement for organ transplantation, and surge in animal testing for drug discovery are expected to drive demand for these products over the next few years

Organ-on-chip Market segmentation

The organ-on-chip market analysis is segmented on the basis of type and region. Depending on type, it is classified into heart-on-chip, human-on-chip, intestine-on-chip, kidney-on-chip, liver-on-chip, and lung-on-chip.

Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Latin America and Middle East and Africa).

Segment Review

Depending on product, the lung-on-chip segment of the organ-on-chip industry dominated the market in 2020, and is expected to remain dominant during the forecast period, owing to lower lung transplantations, which has led to development of laboratory engineered chips to mimic their functions and for drug screening for respiratory disorders.

Organ-on-Chip Market
By Type

Your browser does not support the canvas element.

Lung-on-chip segment dominated the market in 2020, and is expected to remain dominant during the forecast period

North America exhibited the global organ-on-chip market share in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to increase in prevalence of technologically advanced models, presence of key players, and rise in R & D activities for drug discovery and development. However, Asia-Pacific is anticipated to witness notable organ-on-chip market opportunity, owing to increase in R&D activities, increase in healthcare investment, and various strategies among key players. Moreover, India and China are expected to grow at high CAGR in the Asia-Pacific organ-on-chip market forecast.  

Organ-on-Chip Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

North America exhibited the global organ-on-chip market share in 2020, and is anticipated to remain dominant during the forecast period

The key players operating in the global organ-on-chip market are AxoSim Technologies LLC., BICO Group AB(Visikol), CN Bio Innovations Limited, Elveflow, Emulate, Inc., Insphero AG, Mimetas B.V., Nortis Inc., Organovo Holdings, Inc., and Tara Biosystems.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the organ-on-chip market analysis from 2020 to 2030 to identify the prevailing organ-on-chip market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the organ-on-chip market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global organ-on-chip market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

  • By Type
    • Heart on chip
    • Human on chip
    • Intestine on chip
    • Kidney on chip
    • Liver on chip
    • Lung on chip
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K.
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • India
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Latin America
      • Middle East
      • Africa


Key Market Players

  • AxoSim Technologies LLC
  • BICO Group AB(Visikol)
  • CN Bio Innovations Limited
  • Elveflow
  • Emulate, Inc.
  • Insphero AG
  • Mimetas B.V.
  • Nortis Inc.
  • Organovo Holdings, Inc.
  • Tara Biosystems
 
  • CHAPTER 1:INTRODUCTION

    • 1.1.Report description

    • 1.2.Key market segments

    • 1.3.Key benefits to the stakeholders

    • 1.4.Research Methodology

      • 1.4.1.Secondary research

      • 1.4.2.Primary research

      • 1.4.3.Analyst tools and models

  • CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study

    • 2.2.CXO Perspective

  • CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope

    • 3.2.Key findings

      • 3.2.1.Top investment pockets

    • 3.3.Porter’s five forces analysis

    • 3.4.Top player positioning

    • 3.5.Market dynamics

      • 3.5.1.Drivers

      • 3.5.2.Restraints

      • 3.5.3.Opportunities

    • 3.6.COVID-19 Impact Analysis on the market

  • CHAPTER 4: ORGAN-ON-CHIP MARKET, BY TYPE

    • 4.1 Overview

      • 4.1.1 Market size and forecast

    • 4.2 Heart on chip

      • 4.2.1 Key market trends, growth factors and opportunities

      • 4.2.2 Market size and forecast, by region

      • 4.2.3 Market analysis by country

    • 4.3 Human on chip

      • 4.3.1 Key market trends, growth factors and opportunities

      • 4.3.2 Market size and forecast, by region

      • 4.3.3 Market analysis by country

    • 4.4 Intestine on chip

      • 4.4.1 Key market trends, growth factors and opportunities

      • 4.4.2 Market size and forecast, by region

      • 4.4.3 Market analysis by country

    • 4.5 Kidney on chip

      • 4.5.1 Key market trends, growth factors and opportunities

      • 4.5.2 Market size and forecast, by region

      • 4.5.3 Market analysis by country

    • 4.6 Liver on chip

      • 4.6.1 Key market trends, growth factors and opportunities

      • 4.6.2 Market size and forecast, by region

      • 4.6.3 Market analysis by country

    • 4.7 Lung on chip

      • 4.7.1 Key market trends, growth factors and opportunities

      • 4.7.2 Market size and forecast, by region

      • 4.7.3 Market analysis by country

  • CHAPTER 5: ORGAN-ON-CHIP MARKET, BY REGION

    • 5.1 Overview

      • 5.1.1 Market size and forecast

    • 5.2 North America

      • 5.2.1 Key trends and opportunities

      • 5.2.2 North America Market size and forecast, by Type

      • 5.2.3 North America Market size and forecast, by country

        • 5.2.3.1 U.S.
          • 5.2.3.1.1 Market size and forecast, by Type
        • 5.2.3.2 Canada
          • 5.2.3.2.1 Market size and forecast, by Type
        • 5.2.3.3 Mexico
          • 5.2.3.3.1 Market size and forecast, by Type
    • 5.3 Europe

      • 5.3.1 Key trends and opportunities

      • 5.3.2 Europe Market size and forecast, by Type

      • 5.3.3 Europe Market size and forecast, by country

        • 5.3.3.1 Germany
          • 5.3.3.1.1 Market size and forecast, by Type
        • 5.3.3.2 France
          • 5.3.3.2.1 Market size and forecast, by Type
        • 5.3.3.3 U.K.
          • 5.3.3.3.1 Market size and forecast, by Type
        • 5.3.3.4 Rest of Europe
          • 5.3.3.4.1 Market size and forecast, by Type
    • 5.4 Asia-Pacific

      • 5.4.1 Key trends and opportunities

      • 5.4.2 Asia-Pacific Market size and forecast, by Type

      • 5.4.3 Asia-Pacific Market size and forecast, by country

        • 5.4.3.1 Japan
          • 5.4.3.1.1 Market size and forecast, by Type
        • 5.4.3.2 China
          • 5.4.3.2.1 Market size and forecast, by Type
        • 5.4.3.3 India
          • 5.4.3.3.1 Market size and forecast, by Type
        • 5.4.3.4 Australia
          • 5.4.3.4.1 Market size and forecast, by Type
        • 5.4.3.5 Rest of Asia-Pacific
          • 5.4.3.5.1 Market size and forecast, by Type
    • 5.5 LAMEA

      • 5.5.1 Key trends and opportunities

      • 5.5.2 LAMEA Market size and forecast, by Type

      • 5.5.3 LAMEA Market size and forecast, by country

        • 5.5.3.1 Latin America
          • 5.5.3.1.1 Market size and forecast, by Type
        • 5.5.3.2 Middle East
          • 5.5.3.2.1 Market size and forecast, by Type
        • 5.5.3.3 Africa
          • 5.5.3.3.1 Market size and forecast, by Type
  • CHAPTER 6: COMPANY LANDSCAPE

    • 6.1. Introduction

    • 6.2. Top winning strategies

    • 6.3. Product Mapping of Top 10 Player

    • 6.4. Competitive Dashboard

    • 6.5. Competitive Heatmap

    • 6.6. Key developments

  • CHAPTER 7: COMPANY PROFILES

    • 7.1 AxoSim Technologies LLC

      • 7.1.1 Company overview

      • 7.1.2 Company snapshot

      • 7.1.3 Operating business segments

      • 7.1.4 Product portfolio

      • 7.1.5 Business performance

      • 7.1.6 Key strategic moves and developments

    • 7.2 BICO Group AB(Visikol)

      • 7.2.1 Company overview

      • 7.2.2 Company snapshot

      • 7.2.3 Operating business segments

      • 7.2.4 Product portfolio

      • 7.2.5 Business performance

      • 7.2.6 Key strategic moves and developments

    • 7.3 CN Bio Innovations Limited

      • 7.3.1 Company overview

      • 7.3.2 Company snapshot

      • 7.3.3 Operating business segments

      • 7.3.4 Product portfolio

      • 7.3.5 Business performance

      • 7.3.6 Key strategic moves and developments

    • 7.4 Elveflow

      • 7.4.1 Company overview

      • 7.4.2 Company snapshot

      • 7.4.3 Operating business segments

      • 7.4.4 Product portfolio

      • 7.4.5 Business performance

      • 7.4.6 Key strategic moves and developments

    • 7.5 Emulate, Inc.

      • 7.5.1 Company overview

      • 7.5.2 Company snapshot

      • 7.5.3 Operating business segments

      • 7.5.4 Product portfolio

      • 7.5.5 Business performance

      • 7.5.6 Key strategic moves and developments

    • 7.6 Insphero AG

      • 7.6.1 Company overview

      • 7.6.2 Company snapshot

      • 7.6.3 Operating business segments

      • 7.6.4 Product portfolio

      • 7.6.5 Business performance

      • 7.6.6 Key strategic moves and developments

    • 7.7 Mimetas B.V.

      • 7.7.1 Company overview

      • 7.7.2 Company snapshot

      • 7.7.3 Operating business segments

      • 7.7.4 Product portfolio

      • 7.7.5 Business performance

      • 7.7.6 Key strategic moves and developments

    • 7.8 Nortis Inc.

      • 7.8.1 Company overview

      • 7.8.2 Company snapshot

      • 7.8.3 Operating business segments

      • 7.8.4 Product portfolio

      • 7.8.5 Business performance

      • 7.8.6 Key strategic moves and developments

    • 7.9 Organovo Holdings, Inc.

      • 7.9.1 Company overview

      • 7.9.2 Company snapshot

      • 7.9.3 Operating business segments

      • 7.9.4 Product portfolio

      • 7.9.5 Business performance

      • 7.9.6 Key strategic moves and developments

    • 7.10 Tara Biosystems

      • 7.10.1 Company overview

      • 7.10.2 Company snapshot

      • 7.10.3 Operating business segments

      • 7.10.4 Product portfolio

      • 7.10.5 Business performance

      • 7.10.6 Key strategic moves and developments

    Note: Details on financial performance and strategic moves and developments may not be captured for unlisted companies.

  • LIST OF TABLES

  • TABLE 1. GLOBAL ORGAN-ON-CHIP MARKET, BY TYPE, 2020-2030,($MILLION)
    TABLE 2. ORGAN-ON-CHIP MARKET REVENUE, FOR HEART ON CHIP, BY REGION , 2020-2030,($MILLION)
    TABLE 3. ORGAN-ON-CHIP MARKET HEART ON CHIP BY COUNTRY, 2020-2030,($MILLION)
    TABLE 4. ORGAN-ON-CHIP MARKET REVENUE, FOR HUMAN ON CHIP, BY REGION , 2020-2030,($MILLION)
    TABLE 5. ORGAN-ON-CHIP MARKET HUMAN ON CHIP BY COUNTRY, 2020-2030,($MILLION)
    TABLE 6. ORGAN-ON-CHIP MARKET REVENUE, FOR INTESTINE ON CHIP, BY REGION , 2020-2030,($MILLION)
    TABLE 7. ORGAN-ON-CHIP MARKET INTESTINE ON CHIP BY COUNTRY, 2020-2030,($MILLION)
    TABLE 8. ORGAN-ON-CHIP MARKET REVENUE, FOR KIDNEY ON CHIP, BY REGION , 2020-2030,($MILLION)
    TABLE 9. ORGAN-ON-CHIP MARKET KIDNEY ON CHIP BY COUNTRY, 2020-2030,($MILLION)
    TABLE 10. ORGAN-ON-CHIP MARKET REVENUE, FOR LIVER ON CHIP, BY REGION , 2020-2030,($MILLION)
    TABLE 11. ORGAN-ON-CHIP MARKET LIVER ON CHIP BY COUNTRY, 2020-2030,($MILLION)
    TABLE 12. ORGAN-ON-CHIP MARKET REVENUE, FOR LUNG ON CHIP, BY REGION , 2020-2030,($MILLION)
    TABLE 13. ORGAN-ON-CHIP MARKET LUNG ON CHIP BY COUNTRY, 2020-2030,($MILLION)
    TABLE 14. ORGAN-ON-CHIP MARKET, BY REGION, 2020-2030,($MILLION)
    TABLE 15. NORTH AMERICA ORGAN-ON-CHIP MARKET, BY TYPE, 2020-2030,($MILLION)
    TABLE 16. NORTH AMERICA ORGAN-ON-CHIP MARKET, BY COUNTRY, 2020-2030,($MILLION)
    TABLE 17. U.S. ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 18. CANADA ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 19. MEXICO ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 20. EUROPE ORGAN-ON-CHIP MARKET, BY TYPE, 2020-2030,($MILLION)
    TABLE 21. EUROPE ORGAN-ON-CHIP MARKET, BY COUNTRY, 2020-2030,($MILLION)
    TABLE 22. GERMANY ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 23. FRANCE ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 24. U.K. ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 25. REST OF EUROPE ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 26. ASIA-PACIFIC ORGAN-ON-CHIP MARKET, BY TYPE, 2020-2030,($MILLION)
    TABLE 27. ASIA-PACIFIC ORGAN-ON-CHIP MARKET, BY COUNTRY, 2020-2030,($MILLION)
    TABLE 28. JAPAN ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 29. CHINA ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 30. INDIA ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 31. AUSTRALIA ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 32. REST OF ASIA-PACIFIC ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 33. LAMEA ORGAN-ON-CHIP MARKET, BY TYPE, 2020-2030,($MILLION)
    TABLE 34. LAMEA ORGAN-ON-CHIP MARKET, BY COUNTRY, 2020-2030,($MILLION)
    TABLE 35. LATIN AMERICA ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 36. MIDDLE EAST ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 37. AFRICA ORGAN-ON-CHIP MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 38.AXOSIM TECHNOLOGIES LLC: COMPANY SNAPSHOT
    TABLE 39.AXOSIM TECHNOLOGIES LLC: OPERATING SEGMENTS
    TABLE 40.AXOSIM TECHNOLOGIES LLC: PRODUCT PORTFOLIO
    TABLE 41.AXOSIM TECHNOLOGIES LLC: NET SALES,
    TABLE 42.AXOSIM TECHNOLOGIES LLC: KEY STRATERGIES
    TABLE 43.BICO GROUP AB(VISIKOL): COMPANY SNAPSHOT
    TABLE 44.BICO GROUP AB(VISIKOL): OPERATING SEGMENTS
    TABLE 45.BICO GROUP AB(VISIKOL): PRODUCT PORTFOLIO
    TABLE 46.BICO GROUP AB(VISIKOL): NET SALES,
    TABLE 47.BICO GROUP AB(VISIKOL): KEY STRATERGIES
    TABLE 48.CN BIO INNOVATIONS LIMITED: COMPANY SNAPSHOT
    TABLE 49.CN BIO INNOVATIONS LIMITED: OPERATING SEGMENTS
    TABLE 50.CN BIO INNOVATIONS LIMITED: PRODUCT PORTFOLIO
    TABLE 51.CN BIO INNOVATIONS LIMITED: NET SALES,
    TABLE 52.CN BIO INNOVATIONS LIMITED: KEY STRATERGIES
    TABLE 53.ELVEFLOW: COMPANY SNAPSHOT
    TABLE 54.ELVEFLOW: OPERATING SEGMENTS
    TABLE 55.ELVEFLOW: PRODUCT PORTFOLIO
    TABLE 56.ELVEFLOW: NET SALES,
    TABLE 57.ELVEFLOW: KEY STRATERGIES
    TABLE 58.EMULATE, INC.: COMPANY SNAPSHOT
    TABLE 59.EMULATE, INC.: OPERATING SEGMENTS
    TABLE 60.EMULATE, INC.: PRODUCT PORTFOLIO
    TABLE 61.EMULATE, INC.: NET SALES,
    TABLE 62.EMULATE, INC.: KEY STRATERGIES
    TABLE 63.INSPHERO AG: COMPANY SNAPSHOT
    TABLE 64.INSPHERO AG: OPERATING SEGMENTS
    TABLE 65.INSPHERO AG: PRODUCT PORTFOLIO
    TABLE 66.INSPHERO AG: NET SALES,
    TABLE 67.INSPHERO AG: KEY STRATERGIES
    TABLE 68.MIMETAS B.V.: COMPANY SNAPSHOT
    TABLE 69.MIMETAS B.V.: OPERATING SEGMENTS
    TABLE 70.MIMETAS B.V.: PRODUCT PORTFOLIO
    TABLE 71.MIMETAS B.V.: NET SALES,
    TABLE 72.MIMETAS B.V.: KEY STRATERGIES
    TABLE 73.NORTIS INC.: COMPANY SNAPSHOT
    TABLE 74.NORTIS INC.: OPERATING SEGMENTS
    TABLE 75.NORTIS INC.: PRODUCT PORTFOLIO
    TABLE 76.NORTIS INC.: NET SALES,
    TABLE 77.NORTIS INC.: KEY STRATERGIES
    TABLE 78.ORGANOVO HOLDINGS, INC.: COMPANY SNAPSHOT
    TABLE 79.ORGANOVO HOLDINGS, INC.: OPERATING SEGMENTS
    TABLE 80.ORGANOVO HOLDINGS, INC.: PRODUCT PORTFOLIO
    TABLE 81.ORGANOVO HOLDINGS, INC.: NET SALES,
    TABLE 82.ORGANOVO HOLDINGS, INC.: KEY STRATERGIES
    TABLE 83.TARA BIOSYSTEMS: COMPANY SNAPSHOT
    TABLE 84.TARA BIOSYSTEMS: OPERATING SEGMENTS
    TABLE 85.TARA BIOSYSTEMS: PRODUCT PORTFOLIO
    TABLE 86.TARA BIOSYSTEMS: NET SALES,
    TABLE 87.TARA BIOSYSTEMS: KEY STRATERGIES
  • LIST OF FIGURES

  • FIGURE 1.ORGAN-ON-CHIP MARKET SEGMENTATION
    FIGURE 2.ORGAN-ON-CHIP MARKET,2020-2030
    FIGURE 3.ORGAN-ON-CHIP MARKET,2020-2030
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.ORGAN-ON-CHIP MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 11.ORGAN-ON-CHIP MARKET,BY TYPE,2020(%)
    FIGURE 12.COMPARATIVE SHARE ANALYSIS OF HEART ON CHIP ORGAN-ON-CHIP MARKET,2020-2030(%)
    FIGURE 13.COMPARATIVE SHARE ANALYSIS OF HUMAN ON CHIP ORGAN-ON-CHIP MARKET,2020-2030(%)
    FIGURE 14.COMPARATIVE SHARE ANALYSIS OF INTESTINE ON CHIP ORGAN-ON-CHIP MARKET,2020-2030(%)
    FIGURE 15.COMPARATIVE SHARE ANALYSIS OF KIDNEY ON CHIP ORGAN-ON-CHIP MARKET,2020-2030(%)
    FIGURE 16.COMPARATIVE SHARE ANALYSIS OF LIVER ON CHIP ORGAN-ON-CHIP MARKET,2020-2030(%)
    FIGURE 17.COMPARATIVE SHARE ANALYSIS OF LUNG ON CHIP ORGAN-ON-CHIP MARKET,2020-2030(%)
    FIGURE 18.ORGAN-ON-CHIP MARKET BY REGION,2020
    FIGURE 19.U.S. ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
    FIGURE 20.CANADA ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
    FIGURE 21.MEXICO ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
    FIGURE 22.GERMANY ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
    FIGURE 23.FRANCE ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
    FIGURE 24.U.K. ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
    FIGURE 25.REST OF EUROPE ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
    FIGURE 26.JAPAN ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
    FIGURE 27.CHINA ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
    FIGURE 28.INDIA ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
    FIGURE 29.AUSTRALIA ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
    FIGURE 30.REST OF ASIA-PACIFIC ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
    FIGURE 31.LATIN AMERICA ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
    FIGURE 32.MIDDLE EAST ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
    FIGURE 33.AFRICA ORGAN-ON-CHIP MARKET,2020-2030($MILLION)
    FIGURE 34. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 35. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 36. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 37.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 38.COMPETITIVE DASHBOARD
    FIGURE 39.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 40.AXOSIM TECHNOLOGIES LLC.: NET SALES ,($MILLION)
    FIGURE 41.BICO GROUP AB(VISIKOL).: NET SALES ,($MILLION)
    FIGURE 42.CN BIO INNOVATIONS LIMITED.: NET SALES ,($MILLION)
    FIGURE 43.ELVEFLOW.: NET SALES ,($MILLION)
    FIGURE 44.EMULATE, INC..: NET SALES ,($MILLION)
    FIGURE 45.INSPHERO AG.: NET SALES ,($MILLION)
    FIGURE 46.MIMETAS B.V..: NET SALES ,($MILLION)
    FIGURE 47.NORTIS INC..: NET SALES ,($MILLION)
    FIGURE 48.ORGANOVO HOLDINGS, INC..: NET SALES ,($MILLION)
    FIGURE 49.TARA BIOSYSTEMS.: NET SALES ,($MILLION)

 
 

This section provides opinions of top-level CXOs in the organ-on-chip industry. According to CXOs, organ-on-chip is expected to witness a high adoption rate with an increase in distinct indications and interventions, due to surge in disease load, rise in drug discovery& development, drug screening, and clinical trials.

 

CXOs further state that, organ-on-chip are potential tools for realistic modeling of human physiology and pathology due to the synergistic confluence of microfabrication technologies and tissue engineering. These technologies are expected to provide effective solutions to long-standing issues in medication discovery and individualized disease treatment. The global organ-on-chip market witnessed significant momentum in the healthcare industry and pharmaceutical sector, owing to favorable government policies, conducive regulations abiding organ-on-chip, and growth in the alternative solutions required for animal testing. However, the high development & manufacturing cost of organ-chip-devices is expected to restrict the market growth.

 

North America is expected to witness the highest growth, in terms of revenue during the forecast period, owing to rise in the adoption of technologically advanced research infrastructure, the presence of key players, and advancements in healthcare investments. However, Asia-Pacific is expected to grow significantly, owing to its high R&D activities, increase in investment for technological advancement from key players, and the government.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of organ-on-chip market is $103.44 million in 2020.

A. Lung-on-chip segment dominated the market in 2020, and is expected to remain dominant during the forecast period, owing to lower lung transplantations, which has led to development of laboratory engineered chips to mimic their functions and for drug screening for respiratory disorders and is expected to drive the segment.

A. Increase in prevalence of chronic diseases, rising patient pool and various technological advancements in organ-on-chip is anticipated to drive the market in the forecast period.

A. Top companies such as AxoSim Technologies LLC., BICO Group AB(Visikol), CN Bio Innovations Limited, Elveflow, Emulate, Inc., Insphero AG, Mimetas B.V., Nortis Inc., Organovo Holdings, Inc., and Tara Biosystems held a high market position in 2020.

A. North America is projected to account for a major share of the global organ-on-chip market during the forecast period. U.S. dominated the North America organ-on-chip market owing to increased chronic diseases, adoption of technologically advanced therapies and surge in R & D across the country.

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Organ-on-chip Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,565
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,961
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,939
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,654
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,280
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2021–2030

Published in Feb 2022

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers